Literature DB >> 20307106

Activation of aortic endothelial cells by oxidized phospholipids: a phosphoproteomic analysis.

Alejandro Zimman1, Sharon S Chen, Evangelia Komisopoulou, Bjoern Titz, Roxana Martínez-Pinna, Aarya Kafi, Judith A Berliner, Thomas G Graeber.   

Abstract

Previous studies have shown that oxidized products of the phospholipid PAPC (Ox-PAPC) are strong activators of aortic endothelial cells and play an important role in atherosclerosis and other inflammatory diseases. We and others have demonstrated that Ox-PAPC activates specific signaling pathways and regulates a large number of genes. Using a phosphoproteomic approach based on phosphopeptide enrichment and mass spectrometry analysis, we identified candidate changes in Ox-PAPC-induced protein phosphorylation of 228 proteins. Functional annotation of these proteins showed an enrichment of the regulation of cytoskeleton, junctional components, and tyrosine kinases, all of which may contribute to the phenotypic and molecular changes observed in endothelial cells treated with Ox-PAPC. Many changes in protein phosphorylation induced by Ox-PAPC are reported here for the first time and provide new insights into the mechanism of activation by oxidized lipids, including phosphorylation-based signal transduction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307106      PMCID: PMC2922471          DOI: 10.1021/pr901194x

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  48 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids.

Authors:  Alejandro Zimman; Kevin P Mouillesseaux; Thang Le; Nima M Gharavi; Ann Ryvkin; Thomas G Graeber; Tom T Chen; Andrew D Watson; Judith A Berliner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-16       Impact factor: 8.311

3.  ChromAlign: A two-step algorithmic procedure for time alignment of three-dimensional LC-MS chromatographic surfaces.

Authors:  Rovshan G Sadygov; Fernando Martin Maroto; Andreas F R Hühmer
Journal:  Anal Chem       Date:  2006-12-15       Impact factor: 6.986

4.  Large-scale phosphorylation analysis of mouse liver.

Authors:  Judit Villén; Sean A Beausoleil; Scott A Gerber; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

5.  Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT.

Authors:  Valery N Bochkov; Diana Mechtcheriakova; Marcus Lucerna; Joakim Huber; Roland Malli; Wolfgang F Graier; Erhard Hofer; Bernd R Binder; Norbert Leitinger
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

6.  Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids.

Authors:  M Yeh; N Leitinger; R de Martin; N Onai; K Matsushima; D K Vora; J A Berliner; S T Reddy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

7.  Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium.

Authors:  Anna A Birukova; Panfeng Fu; Santipongse Chatchavalvanich; Dylan Burdette; Olga Oskolkova; Valery N Bochkov; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-12-08       Impact factor: 5.464

8.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

9.  A new algorithm using cross-assignment for label-free quantitation with LC-LTQ-FT MS.

Authors:  Victor P Andreev; Lingyun Li; Lei Cao; Ye Gu; Tomas Rejtar; Shiaw-Lin Wu; Barry L Karger
Journal:  J Proteome Res       Date:  2007-04-19       Impact factor: 4.466

Review 10.  Understanding the role of the cytoskeleton in the complex regulation of the endothelial repair.

Authors:  J S Y Lee; A I Gotlieb
Journal:  Histol Histopathol       Date:  2003-07       Impact factor: 2.303

View more
  19 in total

1.  Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression.

Authors:  Justin M Drake; Nicholas A Graham; Tanya Stoyanova; Amir Sedghi; Andrew S Goldstein; Houjian Cai; Daniel A Smith; Hong Zhang; Evangelia Komisopoulou; Jiaoti Huang; Thomas G Graeber; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 2.  Regulation of platelet function by class B scavenger receptors in hyperlipidemia.

Authors:  Alejandro Zimman; Eugene A Podrez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

3.  DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.

Authors:  Jonathan F Goodwin; Vishal Kothari; Justin M Drake; Shuang Zhao; Emanuela Dylgjeri; Jeffry L Dean; Matthew J Schiewer; Christopher McNair; Jennifer K Jones; Alvaro Aytes; Michael S Magee; Adam E Snook; Ziqi Zhu; Robert B Den; Ruth C Birbe; Leonard G Gomella; Nicholas A Graham; Ajay A Vashisht; James A Wohlschlegel; Thomas G Graeber; R Jeffrey Karnes; Mandeep Takhar; Elai Davicioni; Scott A Tomlins; Cory Abate-Shen; Nima Sharifi; Owen N Witte; Felix Y Feng; Karen E Knudsen
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

4.  Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding.

Authors:  Pamela Y Ting; Christian W Johnson; Cong Fang; Xiaoqing Cao; Thomas G Graeber; Carla Mattos; John Colicelli
Journal:  FASEB J       Date:  2015-05-21       Impact factor: 5.191

5.  Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.

Authors:  Justin M Drake; Evan O Paull; Nicholas A Graham; John K Lee; Bryan A Smith; Bjoern Titz; Tanya Stoyanova; Claire M Faltermeier; Vladislav Uzunangelov; Daniel E Carlin; Daniel Teo Fleming; Christopher K Wong; Yulia Newton; Sud Sudha; Ajay A Vashisht; Jiaoti Huang; James A Wohlschlegel; Thomas G Graeber; Owen N Witte; Joshua M Stuart
Journal:  Cell       Date:  2016-08-04       Impact factor: 41.582

6.  Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.

Authors:  Liudmilla Rubbi; Björn Titz; Lauren Brown; Erica Galvan; Evangelia Komisopoulou; Sharon S Chen; Tracey Low; Martik Tahmasian; Brian Skaggs; Markus Müschen; Matteo Pellegrini; Thomas G Graeber
Journal:  Sci Signal       Date:  2011-03-29       Impact factor: 8.192

Review 7.  Role of phospholipid oxidation products in atherosclerosis.

Authors:  Sangderk Lee; Konstantin G Birukov; Casey E Romanoski; James R Springstead; Aldons J Lusis; Judith A Berliner
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

8.  MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer.

Authors:  Renée de Leeuw; Christopher McNair; Matthew J Schiewer; Neermala Poudel Neupane; Lucas J Brand; Michael A Augello; Zhen Li; Larry C Cheng; Akihiro Yoshida; Sean M Courtney; E Starr Hazard; Gary Hardiman; Maha H Hussain; J Alan Diehl; Justin M Drake; Wm Kevin Kelly; Karen E Knudsen
Journal:  Clin Cancer Res       Date:  2018-05-08       Impact factor: 12.531

Review 9.  High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Georgette M Buga; Greg Hough; Alan C Wagner; Alan M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

Review 10.  Structural identification and cardiovascular activities of oxidized phospholipids.

Authors:  Robert G Salomon
Journal:  Circ Res       Date:  2012-09-14       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.